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Abstract 
The effectiveness of different interventions for challenging behavior (CB) in persons with 
intellectual disabilities (ID) was reviewed by means of a two-phase study. First, a systematic 
review of 137 meta-analyses and reviews on group-study interventions for CB in persons with 
ID was conducted. Based on this review, hypotheses concerning the effectiveness of divergent 
interventions for CB and concerning the impact of variables moderating treatment 
effectiveness were systematically generated. Second, these hypotheses were tested by means 
of a multilevel meta-analysis of single-case and small-n research. Two hundred and eighty-
five studies reporting on 598 individuals were examined. The average treatment effect was 
large and statistically significant. However, this effect varied significantly over the included 
studies and participants. Compared to the meta-analyses and reviews focusing on group-
studies in this research domain, the results of the present multilevel meta-analysis of single-
case and small-n intervention research provided more detailed knowledge on which specific 
CB and intervention components moderate the interventions’ effectiveness. 
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Research highlights 
Effectiveness articles of interventions on challenging behavior (CB) in persons with ID are 
studied. ► Single-case data are combined using a hierarchical linear model meta-analysis. ► 
A large and statistically significant overall treatment effect is found, but the effect varies over 
participants and studies. ► CB topographies and intervention components significantly 
moderate treatment effects.  
 
  
A multilevel meta-analysis of single-case and small-n research on interventions for 
reducing challenging behavior in persons with intellectual disabilities 
1. Introduction 
Individuals with intellectual disabilities (ID) are particularly vulnerable for developing 
challenging behaviors (CBs) (Došen et al., 2007; Emerson et al., 2001; Kahng et al., 2002; 
McIntyre et al., 2002). Those CBs place the individual and his family at risk of serious harm 
to their physical and psychological well-being and they can prevent them from having 
ordinary experiences in the community (Beck et al., 2004; Benson & Brooks, 2008; Blacher 
& McIntyre, 2006; Cooper et al., 2009; Didden et al., 2006; Gavidia-Payne & Hudson, 2002; 
Harvey et al., 2009; Hassiotis et al., 2008; Hastings, 2002; Knapp et al., 2005; Matson & 
Boisjoli, 2009; McIntyre et al., 2002; McMillan et al., 2004). Nowadays, divergent 
intervention strategies are used to reduce CB among persons with ID, including biological, 
psychotherapeutic and contextual intervention components (Antonacci et al., 2008; Beail, 
2003, Deb et al., 2007; Došen & Day, 2001; Gavidia-Payne & Hudson, 2002; Grey & 
Hastings, 2005; Heyvaert et al., 2010; Kahng et al., 2002; McGillivray & McCabe, 2006; 
Prout & Nowak-Drabik, 2003; Sohanpal et al., 2007; Sturmey, 2004; Taylor, 2002, 2005; 
Willner, 2005).  
Answering the call of Campbell (2003) in this journal to systematically compare 
behavioral and pharmacological treatment outcomes for reducing CB by means of a 
quantitative review, we include the broad range of pharmacological, behavioral and 
contextual intervention studies in the present study. By doing that, we intend to address the 
question that remained unanswered by previously published SCSn reviews in this research 
domain (e.g., Campbell, 2003; Denis et al., 2011; Didden et al., 2006; Hart & Banda, 2010; 
Harvey et al., 2009; Shogren et al., 2004): do substantial effectiveness differences exist for 
different contextual, behavioral, and pharmacological treatments for CB among persons with 
ID?  
Many primary-level studies have been published in the domain of intervention 
research for reducing CB among persons with ID, and a considerable amount of these studies 
concern small numbers of participants. Meta-level research is needed to examine and compare 
the broad range of intervention components studied in those primary-level articles: combining 
the treatment results from several participants studied under diverging circumstances provides 
insights concerning the general applicability of treatment-effect findings and concerning 
factors that moderate the treatment effect (Van den Noortgate & Onghena, 2008).  
Although several recent articles provide a review on interventions for CB for persons 
with ID (e.g., Brylewski & Duggan, 2004; Chan et al., 2010; Dinca et al., 2005; Hassiotis & 
Hall, 2008; Heyvaert et al., 2010; Hogg et al., 2001; Lotan & Gold, 2009; Matson & Neal, 
2009; Parikh et al., 2008; Prout & Nowak-Drabik, 2003; Shogren et al., 2004; Sohanpal et al., 
2007; Taylor, 2002; Thomson et al., 2009a, 2009b), with only a few exceptions (e.g., 
Campbell, 2003; Denis et al., 2011; Didden et al., 2006; Hart & Banda, 2010; Harvey et al., 
2009; Shogren et al., 2004) these meta-analyses and reviews focus on group-studies, and 
exclude a sizeable part of the empirical evidence that is published in this research domain: the 
single-case and small-n (SCSn) research. In contrast to group-studies that investigate the 
effectiveness of treatments by comparing groups and present aggregated data for a group of 
participants, SCSn studies report effectiveness data for each participant separately. SCSn 
designs refer to experiments in which one participant (SC) or a small number of participants 
(Sn) is repeatedly observed under the levels of at least one manipulated independent variable 
(Onghena, 2005). Compared to the group-comparison design, some advantages of the SCSn 
design in the research domain of interventions for reducing CB in persons with ID are its 
focus on the individual providing an in-depth insight into the behavior of a single case, the 
allowance of detailed analysis of characteristics of ‘nonresponders’ as well as ‘responders’ to 
interventions, the study of behavior evolution through a large number of repeated 
observations, and its cost-effective approach (Horner et al., 2005; Van den Noortgate & 
Onghena, 2007). 
It is suggested that the results of published SCSn research could significantly differ 
from group-studies (e.g., Newcombe, 1987; Thornton & Lee, 2000). Accordingly, concerning 
a single research topic a meta-analysis exclusively including SCSn research could lead to 
different conclusions than a meta-analysis exclusively including group-studies. By 
systematically comparing the results of recently published SCSn research with the 
conclusions of meta-analyses and systematic reviews based on group-studies on interventions 
for reducing CB in persons with ID, the present study intends to examine whether there exists 
substantial differences between both groups of studies.  
In order to achieve this goal, a meta-analysis of SCSn research will be performed, 
preceded by a systematic review of meta-analyses and reviews on group-study interventions 
for CB in persons with ID. The preceding systematic review will provide an overview of the 
recent developments in this domain, and will allow to systematically generate hypotheses 
concerning the effectiveness of divergent interventions for CB, and concerning the impact of 
variables moderating this treatment effectiveness. These hypotheses will be tested in the meta-
analysis of SCSn research on this topic. Finally, we will answer the posed question whether 
there exists substantial differences between recently published SCSn research, and meta-
analyses and systematic reviews based on group-studies in the research domain of 
interventions for reducing CB in persons with ID. This approach is unprecedented in this 
research domain.  
Supplementary to the published SCSn meta-analyses on treatments of CBs in persons 
with ID that mainly apply nonregression approaches like percentages of nonoverlapping data 
(PND)
1
 (Campbell, 2003; Didden et al., 2006; Hart & Banda, 2010; Harvey et al., 2009; 
Shogren et al., 2004), we choose to use a regression approach for quantifying outcomes of 
single-subject research. We applied an adaptation of the general hierarchical linear model that 
can be used for a multilevel meta-analysis of SCSn research measures of effect (Bryk & 
Raudenbush, 1992; Van den Noortgate & Onghena, 2003a, 2003b), in which the variance in 
observed treatment effects is split up in sampling variance, variance between participants 
from the same study, and variance between studies, and in which we try to explain this 
variation by the inclusion of case and study characteristics. Advantages of this approach are 
described in papers of Van den Noortgate and Onghena (2003c, 2007, 2008). 
Summarizing, the present study intends to answer the following questions: (a) What is 
the overall effect of different contextual, behavioral, and pharmacological interventions for 
CB among persons with ID?; (b) Which characteristics of participants, of the context of the 
study, and of the intervention moderate this effect?; and (c) Are the conclusions for SCSn 
studies and group-studies equivalent?  
2. Generating hypotheses concerning moderating variables 
2.1. Literature search and criteria for inclusion 
Relevant reviews were identified through systematic searches of three electronic 
databases as well as hand searches of 32 key scientific journals known to publish research on 
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 PND summarizes the efficacy of single-subject interventions by calculating the percentage of 
intervention data points that do not overlap with the highest or lowest baseline data points 
(Campbell, 2003). A recent quantitative synthesis of Maggin et al. (2011) showed that PND is 
the most often used effect-size metric in the meta-analysis of single-subject research for 
students with disabilities. 
treatments for persons with ID. Afterwards, we systematically examined the bibliographies of 
the identified articles.  
We included reviews describing intervention effects for CB among persons with ID, 
and possibly also reporting on variables moderating the intervention effects. All types of 
quantitative and qualitative reviews were eligible (e.g., statistical meta-analysis, narrative 
review, meta-study, meta-synthesis, meta-summary, aggregated analysis). However, we 
excluded reviews exclusively based on SCSn research (e.g., Campbell, 2003; Denis et al., 
2011; Didden et al., 2006; Hart & Banda, 2010; Harvey et al., 2009; Shogren et al., 2004), in 
order to avoid overlap between our two databases: the meta-analyses and reviews database, 
and the SCSn database. We only included reviews published in the period January 2000 - 
April 2011. We did not apply language-related inclusion/exclusion criteria. We did not assign 
weights to the retrieved articles, e.g., based on the type of the review.  
First, the electronic searches of the databases Eric, Pubmed, and Web of Science 
involved the combining of search strings for CB with search strings for ID (Table 1), and with 
the search terms ‘review’, ‘synthesis’, and ‘meta-analysis’. This search located 103 reviews 
that met our inclusion criteria. Second, a manual search of reviews published in the 32 
journals summed up in Table 2 was conducted, by systematically screening the indexed 
articles. This search additionally retrieved 30 reviews that met our inclusion criteria. Third, 
the bibliographical lists of all reviews obtained through the electronic databases and journals 
searches were scrutinized. Nine reviews not yet identified were retrieved. In order to avoid 
overlap between the two databases, we did not include six reviews based on SCSn research. 
The final database included 136 reviews, all written in English. 
We systematically generated an overview of the main results of the retrieved reviews 
in Microsoft Excel, and cross-compared and tabulated the variables reported to have a 
possible moderating effect on the intervention effects.  
2.2. Hypotheses and study variables 
Based on the systematic review of the meta-analyses and reviews on group-study 
interventions for CB in persons with ID, we hypothesized that the interventions would on 
average lead to a reduction of CB, since the greater part of the meta-analyses and reviews 
concluded that the studied interventions led to a reduction of CB. Concerning 
pharmacological interventions, some authors claim that there is convincing evidence for the 
effectiveness of some medication - particularly for the atypical antipsychotic medication 
risperdone - (e.g., Barnard et al., 2002; Deb et al., 2007; Grey & Hastings, 2005), although 
many authors assert that pharmacological interventions for the present lack sufficient 
empirical effectiveness and should not be the first treatment option (e.g., Antonacci et al., 
2008; Benson & Brooks, 2008; Brylewski & Duggan, 2004; Dinca et al., 2005; La Malfa et 
al., 2006; Matson & Neal, 2009; Sohanpal et al., 2007; Taylor, 2002; Thomson et al., 2009a, 
2009b). Additionally, concerns are raised about their adverse effects (e.g., Aman et al., 2000; 
Berry-Kravis & Potanos, 2004; Deb et al., 2007; La Malfa et al., 2006; Matson et al., 2000; 
Parikh et al., 2008; Sohanpal et al., 2007). Regarding psychotherapeutic and contextual 
interventions, there exist several studies advocating their effectiveness (e.g., Ager & O’May, 
2001; Carr et al., 2009; Gavidia-Payne & Hudson, 2002; Grey & Hastings, 2005; Harvey et 
al., 2009; Prout & Nowak-Drabik, 2003; Shogren et al., 2004), although some studies 
conclude that the evidence is still too scant (e.g., Antonacci et al., 2008; Gustafsson et al., 
2009; Hassiotis & Hall, 2008; Sturmey, 2004; Willner, 2005).  
Additionally, based on the review of the retrieved meta-analyses and reviews we 
systematically generated a list of variables that were reported to have a possible moderating 
impact on the treatment effectiveness (Table 3). Based on our review, we hypothesized that 
especially the target CB, the specific intervention components (bio/psycho/social), and the 
presence of pretreatment functional analysis could function as moderators. 
3. Methods 
3.1. Literature search and criteria for inclusion 
Parallel to the literature search for meta-analyses and reviews concerning group-
studies, for the multilevel meta-analysis of SCSn relevant primary-level research reports 
published in the period January 2000 - April 2011 were identified through systematic searches 
of (1) the databases Eric, Pubmed, and Web of Science applying the search strings shown in 
Table 1, (2) 31 key scientific journals summed up in Table 2 (the journal Developmental 
Disabilities Research Reviews was excluded from this search, since this journal only 
publishes reviews, and not primary-level SCSn studies), and (3) the bibliographical lists of the 
papers identified in steps (1) and (2).  
The literature search for this meta-analysis aimed at retrieving single-case studies and 
small-n studies reporting on intervention effects on CB among persons with ID. This contrasts 
with the data collection for the qualitative preparatory phase, that pursued to retrieve reviews 
including group-studies on this topic. Research reports that met the following criteria were 
included: (a) The study aim was the reduction of CB among persons with ID; (b) The single-
case or small-n study reported measures of the CB of a participant under baseline and 
treatment conditions, with each containing at least two data points. A study was excluded if a 
group of participants was described but no individual characteristics were presented or if the 
raw data representing the level of CB under baseline and treatment conditions was not 
reported for each participant separately or could not be accurately retrieved from for instance 
a graph. Consequently, studies only reporting percentages of reduction of CB were excluded, 
as well as studies only reporting aggregated data for multiple participants. We included all 
types of SCSn designs that answered to our inclusion/exclusion criteria. Again, we did not 
apply language-related inclusion/exclusion criteria.  
First, the electronic searches of the three databases located 172 unique research reports 
that met our inclusion criteria. Second, the manual search of papers published in the 31 
journals additionally retrieved 108 research reports that met our inclusion criteria. Third, 
searching the bibliographical lists of all included papers identified five other relevant studies. 
The final database included 285 studies reporting on 598 individuals. All included studies 
were written in English. There were 155 single-case studies and 130 small n ( > 1) studies. 
3.2. Data extraction 
3.2.1. Study variables 
All retrieved studies were reviewed and coded for each of the variables described in 
Table 3 and Table 4. Several participant, context, and intervention variables were coded, as 
well as the meta-analytic variables Publication year and Study quality. In order to code the 
latter variable we applied the Single-case Experimental Design (SCED) Scale developed by 
Tate et al. (2008): ten items were used to assess the methodological quality of and the use of 
statistical analyses in each included SCSn study. The SCED Scale is characterized by high 
levels of inter-rater reliability. In the study of Tate et al. (2008) inter-rater reliability was first 
studied between six experienced raters using intra-class correlation (ICC), each rating twenty 
papers published in the 10-year period 1996 to 2005 that were randomly selected from 312 
reports archived in PsycBITE. Inter-rater reliability for the total score was high (for individual 
raters: overall ICC = .84 with 95% confidence interval .73-.92; for consensus ratings between 
pairs of raters: overall ICC = .88 with 95% confidence interval .78-.95). Second, the results 
were replicated with two independent novice raters who were trained in the use of the scale 
(ICC = .88 with 95% confidence interval .73-.95). 
3.2.2. Treatment effectiveness 
Next to the coding of possible moderating variables, information concerning treatment 
effectiveness was extracted from the research reports. These effectiveness data were presented 
graphically in the primary studies. The raw data were retrieved with the aid of the UnGraph 
Version 5 software, a digitizer program that gives X,Y coordinates of lines or points on 
scanned images (Biosoft, 1997-2011). In a study of Shadish et al. (2009) extraction with 
UnGraph proved highly valid and reliable over several different kinds of analyses. 
Afterwards, the raw data were imported in Microsoft Excel. 
3.2.3. Reliability of coding 
Ten percent of the included studies were randomly selected, and analyzed by two 
researchers. Interrater agreement was calculated on each study variable by dividing the 
number of agreements by the number of agreements plus disagreements. The interrater 
reliability was 92.01%. Disagreements were afterwards resolved by discussion between the 
two researchers, and the corrected codes were used for the meta-analysis.  
3.3. Data analysis 
The data of our meta-analysis show a hierarchical three-level structure: 285 primary 
studies are included in the meta-analysis (between-studies level), that describe 598 individuals 
with ID and CB (between-participants level), and for each individual repeated measurements 
of CB are reported (within-participants level). Accordingly, we choose to apply an adaptation 
of the general hierarchical linear model that can be used for a multilevel meta-analysis of 
SCSn measures of effect, described in publications of Van den Noortgate and Onghena 
(2003a, 2003b, 2003c, 2007, 2008). An advantage of this approach is that by modeling the 
variation within participants, between participants of the same study, and between studies, it 
accounts for the possible dependency that may result from this three-level nesting (Van den 
Noortgate & Onghena, 2008). In this model, the coefficient that indicates the magnitude of the 
effect of the intervention on the CB of a participant can be considered as a standardized 
difference between means, since it is equal to the difference in condition means, divided by 
the within-condition standard deviation (Van den Noortgate and Onghena, 2008). However, 
Van den Noortgate and Onghena (2008) note that standardized mean differences from group-
comparison and SC designs are not directly comparable: in SC studies effect sizes are 
calculated on the basis of scores from the same participant, while in group-comparison 
studies two independent groups are compared and scores within each condition are derived 
from different participants. The standard deviation in a group-comparison study is influenced 
by between-participant as well as within-participant variation, while the within-phase standard 
deviation of the scores from a single participant in a SC design refers only to differences 
within participants (Van den Noortgate and Onghena, 2008).  
The SAS software Version 9.2 was used to conduct the present multilevel meta-
analysis of SCSn studies on interventions for reducing CB in persons with ID. The SAS 
procedure MIXED provided estimates and tests of the overall effect, the overall intercept, and 
the covariance parameters (see Table 5). Descriptive statistics for each variable (see Table 4) 
and tests on the moderating impact of each variable on the treatment effectiveness were 
conducted (see Table 5).  
Additionally, using the metafor package in R (Viechtbauer, 2010) we checked for 
publication bias by generating a funnel plot (Rothstein et al., 2005) and testing for funnel plot 
asymmetry (Egger et al., 1997a). 
4. Results 
4.1. Three-level model 
First, let us look at the three-level random effects regression model without 
moderators, presented as ‘Model 1’ in Table 5 (see Van den Noortgate & Onghena, 2008). 
This analysis reveals that on average the interventions for CB are highly effective: in 
comparison to the baseline conditions, the level of CB is 2.96 standard deviations lower in the 
treatment conditions. A Wald test acknowledges that this reduction in CB is statistically 
significant, Z = -13.16, p < .0001. Looking at the covariance parameter estimates, we notice 
that the intervention effects vary significantly over studies, with an estimated variance of 
3.32, Z = 3.67, p = .0001. The intervention effects vary significantly over the included 
participants too, with an estimated variance of 20.57, Z = 15.01, p < .0001. 
Second, in order to examine which variables can explain this variation of the 
intervention effects over the participants and the studies, we look at the three-level meta-
analysis model including all potential moderators (see Van den Noortgate & Onghena, 2008) 
that are listed in Tables 3 and 4. In table 5, Model 2 shows a statistically significant 
moderating effect of the variables Age (Z = -2.80, p = .0051), Diagnosis of autism spectrum 
disorder (Z = -3.43, p = .0006), the CB-type Aggression (Z = 10.29, p < .0001), the CB-type 
Destructive behavior (Z = 2.59, p = .0096), the intervention component Manipulating 
antecedent factors (Z = -2.80, p = .0052), and the intervention component Informing, 
educating, training the environment (Z = -2.67, p = .0076). For the other variables, no 
statistically significant moderating effect is found. However, testing a meta-analytical model 
including a large amount of potential moderators brings along the risk of misinterpretation 
due to multicollinearity. Therefore, we added each of the potential moderators separately to 
the regression model. This analysis confirms that there is a statistically significant moderator 
effect of these six variables: Age (Z = -9.94, p < .0001), Diagnosis of autism spectrum 
disorder (Z = -6.25, p < .0001), the CB-type Aggression (Z = 6.09, p < .0001), the CB-type 
Destructive behavior (Z = -3.23, p = .0013), the intervention component Manipulating 
antecedent factors (Z = -5.29, p < .0001), and the intervention component Informing, 
educating, training the environment (Z = -6.83, p < .0001). Interpreting these results for 
Model 2, we see that the interventions for CB on average turn out to be less effective for 
persons with aggression or destruction as CB-type, and more effective for included 
participants with a diagnosis of autism spectrum disorder. When participants are treated by an 
intervention including the component Manipulating antecedent factors or Informing, 
educating, training the environment, the results are on average better. The expected effect for 
persons treated by an intervention at older age is on average better compared to the effects for 
younger participants
2
. 
Third, we combined these six moderators in the final three-level meta-analysis model 
(‘Model 3’ in Table 5), excluding other predictors (see Van den Noortgate & Onghena, 2008). 
Model 3 shows a statistically significant moderating effect of the variables Age (Z = -2.15, p = 
.0312), Diagnosis of autism spectrum disorder (Z = -2.91, p = .0037), the CB-type Aggression 
(Z = 9.76, p < .0001), and the intervention component Manipulating antecedent factors (Z = -
2.42, p = .0155). However, in contrast to Model 2, the variables Destructive behavior and 
Informing, educating, training the environment do not play a significant moderating effect in 
Model 3 (respectively Z = 1.77, p = .0762; Z = -1.74, p = .0810). The interpretation of the 
results for Model 3 is analogue to Model 2: interventions on average turn out to be less 
effective for persons with aggression as CB-type. Interventions are on average more effective 
for persons with a diagnosis of autism spectrum disorder, for older participants, and when the 
intervention includes the component Manipulating antecedent factors. 
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 For the continuous moderator Age, the regression coefficient (in Model 2 this coefficient is -
0.06) indicates the increase of the effect when the age increases with one unit (i.e., one year).  
4.2. Sensitivity analysis 
Figure 1 displays the box and whisker diagram of the standardized random effects for 
the individual participants. There seem to be six outlying participants (all belonging to 
different studies) deviating more than three standard deviations from zero, including one 
extremely outlying case showing a standardized random effect of 15.64. Since these outlying 
effects do not seem to be based upon incorrect values (that could lead to a distorted view of 
the population), the participants are not omitted from the analysis. However, as a check of the 
influence of these outliers on the conclusions, we performed a sensitivity analysis by 
comparing the full dataset, the dataset without the one extreme outlier, and the dataset without 
the six outliers. By removing these outliers, the overall effect of -2.96 (which means that the 
level of CB is on average 2.96 standard deviations lower in the treatment conditions, 
compared to baseline conditions) is reduced to respectively -2.90 and -2.69. For all three 
datasets, the Wald test shows that on average this reduction in CB is statistically significant, 
with respectively: Z = -13.16, p < .0001; Z = -14.58, p < .0001; and Z = -18.44, p < .0001. 
This means that for all three datasets the interventions are on average highly effective in 
reducing CB.  
Applying the analyses described in section 4.1. under ‘Model 1’ for the databases 
without the one extreme outlier, and without the six outliers, we see that the variance of effect 
between participants for the latter database is considerably lower compared to the original 
database. However, the intervention effects still vary significantly over the included 
participants for both databases: the estimated variance is 11.76 for the database without the 
one extreme outlier (SD = 0.95; Z = 12.36, p < .0001) and 3.48 for the database without the 
six outliers (SD = 0.30; Z = 11.54, p < .0001). So, even after omitting the six most extreme 
scoring participants from the analysis, the intervention effects still vary significantly over the 
included participants. 
When we implement the moderator analyses (described in section 4.1. under ‘Model 
2’) for the database without the six outliers, we conclude that from the six variables that had a 
significant moderating effect for the original database (i.e., Age, Diagnosis of autism spectrum 
disorder, Aggression, Destructive behavior, Manipulating antecedent factors, and Informing, 
educating, training the environment), only four variables remain to have a significant 
moderating effect: Diagnosis of autism spectrum disorder (Z = -2.17, p = .0299), the CB-
types Aggression (Z = 9.95, p < .0001) and Destructive behavior (Z = 2.23, p = .0258), and 
the intervention component Manipulating antecedent factors (Z = -2.70, p = .0070). 
Interpreting these results for Model 2 for the database without the six outliers, we see that the 
interventions for CB on average turn out to be less effective for persons with aggression or 
destruction as CB-type, and more effective for included participants with a diagnosis of 
autism spectrum disorder. When participants are treated by an intervention including the 
component Manipulating antecedent factors the intervention effects are on average better.  
Subsequently, we combined these four moderators in the final three-level meta-
analysis model for the database without the six outliers, excluding other predictors (‘Model 
3’). Model 3 only shows a statistically significant moderating effect of the variables 
Aggression (Z = 9.41, p < .0001) and Manipulating antecedent factors (Z = -2.94, p = .0033). 
In contrast to Model 2, the variables Destructive behavior and Diagnosis of autism spectrum 
disorder do not play a significant moderating effect in Model 3 (respectively Z = 1.51, p = 
.1306; Z = -1.35, p = .1781). The interpretation of these final results are that interventions on 
average turn out to be less effective for persons with aggression as CB-type; and that they are 
on average more effective when the intervention includes the component Manipulating 
antecedent factors. 
Summarizing the moderator analysis results for the original database, of all tested 
variables six where found to have a statistically significant moderating effect (for ‘Model 2’: 
Age; Aggression; Destructive behavior; Diagnosis of autism spectrum disorder; Informing, 
educating, training the environment; and Manipulating antecedent factors). When 
subsequently only these six variables were combined in one model, only four of them 
remained to show statistically significant moderating effects (for ‘Model 3’: Age, Aggression, 
Diagnosis of autism spectrum disorder, and Manipulating antecedent factors). However, 
when omitting the six most extreme participants from the moderator analysis (see Figure 1), 
of all tested variables four where found to have a statistically significant moderating effect 
(for ‘Model 2’: Aggression, Destructive behavior, Diagnosis of autism spectrum disorder, and 
Manipulating antecedent factors). When subsequently only these four variables were 
combined in one model, only two of them remained to show statistically significant 
moderating effects (for ‘Model 3’: Aggression and Manipulating antecedent factors).  
4.3. Publication bias analysis 
Each black dot in Figure 2 represents the observed outcome for one participant 
(horizontal axis) plotted against the corresponding standard error (vertical axis). The vertical 
line in Figure 2 shows the estimate based on Model 1, the random effects model without 
moderators. A pseudo confidence interval area is depicted around this estimate, with bounds 
equal to +-1.96 times the standard error value (Viechtbauer, 2010). As expected, by visually 
inspecting this plot we find some evidence for publication bias: the plot is not symmetric. On 
the left side of the plot, we notice six outlying points, referring to six outlying participants that 
were also detected in Figure 1. The regression test for funnel plot asymmetry with standard 
error as predictor described by Viechtbauer (2010) confirms that there is significant 
asymmetry in the funnel plot: t(596) = -7.03, p < .0001. 
  
4.4. Comparing the effects for SCSn- and group-studies 
In the following paragraph, we discuss the comparison between the hypotheses based 
on the studied meta-analyses and systematic reviews, and the results of our multilevel meta-
analysis of SCSn research concerning (a) the effectiveness of biological, psychotherapeutic 
and contextual interventions for CB among persons with ID, and concerning (b) the impact of 
variables moderating the treatment effectiveness.  
(a) The generated hypothesis stating that the interventions would on average lead to a 
reduction of CB (see section 2.2.) was confirmed: our meta-analysis of SCSn research yields a 
high overall intervention effect that is statistically significant. Looking at Table 4, we find 
evidence endorsing the positive effects of psychotherapeutic and contextual intervention 
components, but no evidence for an overall positive effect of pharmacological interventions. 
These findings correspond to what we concluded from the preceding systematic review of 
meta-analyses and reviews based on group-study interventions for CB in persons with ID (see 
section 2.2.).  
(b) We hypothesized that all variables listed in Table 3 could have a moderating 
impact on the treatment effectiveness, but that especially the target CB, the specific 
intervention components (bio/psycho/social), and the presence of pretreatment functional 
analysis would function as variables moderating the treatment effectiveness (see section 2.2.). 
The hypotheses suggesting the potential influence of the target CB (for the variable 
Aggression - the other moderating CB effects are not significant) and the specific intervention 
components (for the variable Manipulating antecedent factors - the other moderating 
intervention component effects are not significant) were confirmed in the meta-analysis of 
SCSn studies. Inconsistent with our hypothesis, we found no evidence that the intervention 
effects significantly depend on the presence of pretreatment functional analysis: looking at 
Table 4 we see that the treatment effects for studies including pretreatment functional analysis 
are in general better than in studies lacking pretreatment functional analysis, but this effect is 
not significant (Table 5). After controlling for six extreme outliers, our multilevel meta-
analysis of SCSn research found no significant evidence for the moderating effect of other 
variables besides the variables Aggression and Manipulating antecedent factors (see section 
4.2.).  
Concluding from (a) and (b), we state the results of the multilevel meta-analysis of 
SCSn research to a large extent correspond with the conclusions of meta-analyses and reviews 
focusing on group-studies in this research domain; and that the present multilevel meta-
analysis provides more detailed knowledge on which specific CB (i.e., Aggression) and 
intervention components (i.e., Manipulating antecedent factors) significantly moderate the 
overall intervention effect. 
5. Discussion  
The present multilevel meta-analysis aimed to systematically study and compare the 
effectiveness of different interventions for CB in people with ID that are described in SCSn 
research, and to examine the impact of variables moderating the treatment effectiveness. 
Since the overall intervention effect is high (-2.96) and statistically significant (Z = -13.16, p 
< .0001), we conclude that on average the interventions for CB in people with ID reported in 
the SCSn studies are highly effective.  
However, we have to make three comments concerning the generalization of our 
results. First, although the overall intervention effect is high, the effect varies significantly 
over studies (the estimated variance is 3.32, Z = 3.67, p = .0001) and over the included 
participants (the estimated variance is 20.57, Z = 15.01, p < .0001). For the variance of effect 
between studies, this result means that based on the normal distribution, we can say that 95% 
of the study-effects vary from -6.53 (i.e., -2.96 – 1.96*√3.32) to + 0.61 (i.e., -2.96 + 
1.96*√3.32), with negative values indicating reductions in CB (desired), and positive values 
indicating increases in CB. Likewise, for the variance of effect between participants, this 
result means that based on the normal distribution, we expect for a typical study that 95% of 
the participants-effects vary from -11.85 (i.e., -2.96 – 1.96*√20.57) to + 5.93 (i.e., -2.96 + 
1.96*√20.57). We see that especially the variance of effect between participants is extremely 
high, pointing to the fact that it is possible that the interventions do not have the desired effect 
for several participants. Looking at the datasets without the one extreme outlier and without 
the six outliers (see 4.2.), the variance of effect between participants is considerably lower 
compared to the original database, although the intervention effects still vary significantly 
over the included participants for both databases: the estimated variance is respectively 11.76 
(SD = 0.95; Z = 12.36, p < .0001) and 3.48 (SD = 0.30; Z = 11.54, p < .0001). So, although 
even after omitting the six most extreme scoring participants from the analysis the Wald test 
showed that on average the reduction in CB is still statistically significant (see section 4.2.), 
these intervention effects vary significantly over the included participants.  
A second comment concerns publication bias. After visually inspecting the generated 
funnel plot (Figure 2), the regression test for funnel plot asymmetry confirmed the significant 
asymmetry of this plot and the presence of publication bias (see 4.3.). Publication bias boils 
down to the problem that since ‘negative’ (i.e., finding no reduction of the CB due to the 
intervention, but an increase of the CB) and null-finding (i.e., finding nor a reduction nor an 
increase of the CB due to the intervention) studies are often not reported and published, and 
therefore not included in reviews and meta-analyses, most treatments tend to be less effective 
in clinical practice than the published research suggests. In comparison to group-studies, 
especially SCSn research is more unlikely to be reported and published unless describing 
significant results (Thornton & Lee, 2000). Additionally, although we did not apply language-
related inclusion/exclusion criteria, all studies retrieved by the electronic databases search and 
the bibliographical lists search were written in English. Our search in relevant journals only 
concerned English-written journals. The fact that all included studies are written in English 
could additionally explain some of the found publication bias: authors are more likely to 
publish their studies in an English-language journal if the results are statistically significant 
(Egger et al., 1997b; Rothstein et al., 2005).  
Third, there was some overlap between the primary-level research studies included in 
the meta-analyses and reviews, that were analyzed in our systematic review preceding our 
multilevel meta-analysis. Some of the primary-level research studies were discussed in more 
than one meta-analysis or review included in our systematic review. Consequently, it is 
possible that some of the primary-level research studies had a relatively stronger influence on 
the conclusions of our systematic review than other primary-level research studies. Since 
several of the meta-analyses and reviews analyzed in our systematic review did not include a 
list describing all included primary-level research studies, it was difficult to address this 
drawback.      
Notwithstanding these limitations, the present study has several strengths. First, it is 
one of the few meta-analyses in the domain of intervention research on CB in people with ID 
that includes SCSn research. Although SCSn research represents a vast part of the empirical 
evidence published in this research domain, it is often omitted from meta-analyses. Solely 
relying on a certain part of the available evidence (i.e. group-studies) in meta-analyses and 
reviews can endanger the correctness of the generalizations made to the entire population of 
persons with ID and CB. One explanation for the absence of SCSn research in most meta-
analyses is that although a single-case (SC) design is considered as a suitable design for 
drawing valid conclusions about one individual, it is statistically incorrect to generalize the 
results of a SC study to a whole population. However, exploring the generalizability of SC 
results is feasible by replicating the results over other cases, or by aggregating the results from 
several single cases in a meta-analysis (Van den Noortgate & Onghena, 2007, 2008). Another 
explanation is that most of the methodological literature on meta-analysis techniques has 
focused on group-studies (Van den Noortgate & Onghena, 2008). However, during the last 
decades the question how to quantify results from SC studies for purposes of quantitative 
review is more often brought up for discussion (e.g., Allison & Gorman, 1993; Campbell, 
2004; Maggin et al., 2011; Van den Noortgate & Onghena, 2008; White et al., 1989). The 
present meta-analysis illustrates that combining a large number of studies each concerning 
only one or a few participants through a variant of the general hierarchical linear model can 
lead to insightful and important results.  
Second, the present study is the only one in this research domain that systematically 
compares the results of recently published SCSn research with the results of meta-analyses 
and systematic reviews based on group-studies. In section 4.4., we concluded that the results 
of the multilevel meta-analysis of SCSn intervention research on CB for persons with ID to a 
large extent correspond with the results of meta-analyses and reviews focusing on group-
studies in this research domain. However, the present multilevel meta-analysis of SCSn 
research provides more detailed knowledge on which specific CB and intervention 
components significantly moderate the overall intervention effect.  
Furthermore, the found large average treatment effect is consistent with the effects 
reported in previous SCSn meta-analyses on interventions for CB in persons with ID 
(Campbell, 2003; Denis et al., 2011; Didden et al., 2006; Hart & Banda, 2010; Harvey et al., 
2009; Shogren et al., 2004). Variables that were found to have a significant moderator effect 
in these meta-analyses are: presence of pretreatment functional assessment (Campbell, 2003; 
Didden et al., 2006; Harvey et al., 2009), sensory impairment (Denis et al., 2011), study 
design (Didden et al., 2006), duration of treatment (Harvey et al., 2009), diagnosis of autism 
(Harvey et al., 2009), and gender (Shogren et al., 2004). Notice that only the variable 
presence of pretreatment functional assessment was found to be a significant moderator in 
more than one of these SCSn meta-analyses. Although all of these moderators were also 
included in the present SCSn meta-analysis, after the excluding of the six most extreme 
outliers we did not found significant moderating effects for these variables.  
Third, we mention the extensive moderator analyses as a final strength of the present 
study. Based on the preceding review of meta-analyses and reviews of group-studies in this 
research domain, we systematically generated a list of all variables that were reported to have 
a possible moderating impact on the treatment effectiveness, including twelve variables 
related to participant characteristics, ten variables concerning the context of the study, 
fourteen intervention-related variables, and two meta-analytic variables (Table 3). We coded 
all 285 included studies for these 38 variables, computed descriptive statistics and effect sizes 
and associated standard errors for each moderator (Table 4), and generated the three-level 
meta-analysis model including the potential moderators (Table 5). Two variables turned out to 
have a significant moderating impact on the treatment effectiveness, even after controlling for 
six extreme outliers (see section 4.2.): Aggression and Manipulating antecedent factors.  
Our results indicate that the interventions for CB on average turn out to be 
significantly less effective for participants with outwardly directed aggression as CB-type, 
when compared to treated participants without outwardly directed aggression as CB-type. 
Consistent with our findings, the SCSn meta-analysis of Didden et al. (2006) concerning the 
behavioral treatment of CB in individuals with mild ID found relative high mean effect sizes 
associated with stereotypic behavior, and the lowest mean effect sizes associated with 
destructive behaviors and verbal aggression. Additionally, Harvey et al. (2009) found in their 
SCSn meta-analysis of interventions for CB in children with ID that participants with 
disruptive and aggressive behavior generally responded least well to behavior change efforts, 
while children with self-injury, stereotypy, socially inappropriate, and destructive behavior 
responded best to the interventions. 
Finally, we conclude based on our results that when participants are treated by an 
intervention including the component Manipulating antecedent factors, the results are on 
average better than when an intervention without one of these components used. Manipulating 
antecedent factors that increase the probability that a person shows CB has proven to be an 
effective intervention strategy in the ID literature (e.g., Brosnan & Healy, 2011; Conroy & 
Stichter, 2003; Krantz et al., 1993). Often-researched types of antecedent factors in CB 
studies are environmental, instructional, psychological, and social factors (Conroy & Stichter, 
2003). For example, interventions such as reducing task difficulty, making the daily schedule 
more predictable, and providing choice-making opportunities can rather easily be 
implemented, and can strongly decrease the occurrence of CB.  
 To conclude, we summarize the answers provided to the three posed research 
questions. (a) The overall effect of different contextual, behavioral, and pharmacological 
interventions for CB among persons with ID was large and statistically significant. However, 
this effect varied significantly over the included studies and participants. (b) From the 38 
coded characteristics of participants, of the context of the study, and of the intervention, after 
controlling for six extreme outliers, significant evidence was only found for the moderator 
effect of the CB topography aggression, and the intervention component manipulating 
antecedent factors. (c) The results of the multilevel meta-analysis of SCSn research to a large 
extent correspond with the conclusions of meta-analyses and reviews focusing on group-
studies in this research domain. However, the present multilevel meta-analysis provides more 
detailed knowledge on which specific CB and intervention components significantly moderate 
the overall intervention effect. Additionally, the found large average treatment effect is 
consistent with the effects reported in previous SCSn meta-analyses on interventions for CB 
in persons with ID. On a regular base, future research should update the present findings, in 
order to add to the evidence base, and to allow researchers and practitioners to make grounded 
decisions when aiming to reduce CB in persons with ID. 
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Table 1 
Search strings for “challenging behavior” and “intellectual disability”, combined with a Boolean AND (between 
both search strings), and Boolean OR’s (within both search strings). 
Search strings for challenging behavior Search strings for intellectual disability 
challenging behavio* intellectual disabilit* 
aberrant behavio* mental retardation 
maladaptive behavio* developmental disabilit* 
problem behavio* learning disabilit* 
behavio* problems intellectual impairment 
self-injury mental handicap 
self-harm mental deficiency 
self-injurious behavio*  
stereotypy  
stereotyped behavio*  
repetitive behavio*  
aggression  
destructive behavio*  
property destruction  
disruptive behavio*  
 
 
  
Table 2 
Manually searched journals. 
American Journal on Intellectual and Developmental Disabilities (American 
Journal on Mental Retardation) 
International Journal of Disability, Development and Education 
Behavior Modification Journal of Abnormal Child Psychology 
Behavior Therapy Journal of Applied Behavior Analysis 
Behavioral Disorders Journal of Applied Research in Intellectual Disabilities 
Behavioral Interventions Journal of Autism and Developmental Disorders 
Behavior Research and Therapy Journal of Behavior Therapy and Experimental Psychiatry 
Brain and Development Journal of Clinical Child & Adolescent Psychology 
British Journal of Clinical Psychology Journal of Consulting and Clinical Psychology 
British Journal of Learning Disabilities Journal of Developmental and Physical Disabilities 
Child and Family Behavior Therapy Journal of Experimental Child Psychology 
Clinical Case Studies Journal of Intellectual and Developmental Disability 
Cognitive and Behavioral Practice Journal of Intellectual Disability Research 
Developmental Disabilities Research Reviews Journal of Positive Behavior Interventions 
Disability & Rehabilitation Journal of Special Education 
Exceptional Children 
Intellectual and Developmental Disabilities (Mental Retardation) 
Research in Developmental Disabilities 
The Journal of ECT 
  
 
 
  
Table 3 
Study variables. 
Participant 
variables 
Age (in years) 
Gender  
Target CB - Self-injurious behavior 
Target CB - Stereotyped behavior 
Target CB - Aggression 
Target CB - Destructive behavior 
Target CB - Disruptive behavior 
Diagnosis of autism spectrum disorder  
Intellectual disability level
 a
 
Sensory impairment  
Motor impairment  
Communicative impairment 
Context variables Design 
Pretreatment functional analysis 
Primary treatment setting  
Primary intervention agent  
Duration of treatment  
Intervention format 
Family involved in treatment  
Peer(s) involved in treatment  
Presence of data/researcher triangulation  
Presence of follow-up data  
Intervention 
variables 
Uni- vs. multicomponent intervention 
Biological intervention 
Biological intervention - Medication 
Psychological intervention 
Psychological intervention - Teaching alternative replacement skills 
Psychological intervention - Reward and praise/attention for positive behaviors 
Psychological intervention - Punishment 
Psychological intervention - Use of restraints 
Psychological intervention - Manipulating antecedent factors 
Psychological intervention - Extinction 
Psychological intervention - Gain insight in perception of CB 
Social-contextual intervention 
Social-contextual intervention  - Informing, educating, training the environment of the participant (parents, caregivers, staff,…) 
Social-contextual intervention  - Adapt the environment to the participant’s needs 
Meta-analytic 
variable 
Publication year  
Study quality 
Notes: CB = challenging behavior; 
a
 If only a range of intellectual disability level was reported, it was categorized as the lower level. 
  
Table 4 
Overview and descriptive statistics for potential moderating variables. 
Variable Value  Descriptive statistics Moderator effect (SE) 
Age Continuous  M = 18; SD = 14.01; range 
= 1-65 
-0.022 (0.017) 
Gender 0 = male; 1 = female n0 = 400; n1= 193 ES 0 -2.842 (0.266); ES 1 -
3.194(0.372) 
CB type – Self-injurious behavior 0 = no self-injurious behavior; 1 = self-injurious 
behavior 
n0 = 353; n1= 245 ES 0 -2.937 (0.232); ES 1 -3.015 
(0.242) 
CB type – Stereotyped behavior 0 = no stereotyped behavior; 1 = stereotyped 
behavior 
n0 = 496; n1= 102 ES 0 -2.913 (0.228); ES 1 -3.211 
(0.290) 
CB type – Aggression 0 = no aggression; 1 = aggression n0 = 282; n1= 316 ES 0 -3.326 (0.231); ES 1 -2.577 
(0.232) 
CB type – Destructive behavior 0 = no destructive behavior; 1 = destructive 
behavior 
n0 = 496; n1= 102 ES 0 -2.916 (0.226); ES 1 -3.188 
(0.244) 
CB type – Disruptive behavior 0 = no disruptive behavior; 1 = disruptive behavior n0 = 363; n1= 235 ES 0 -2.886 (0.229); ES 1 -3.091 
(0.237) 
Diagnosis of autism spectrum 
disorder 
0 = no autism spectrum disorder; 1 = autism 
spectrum disorder 
n0 = 363; n1= 235 ES 0 -2.831 (0.260); ES 1 -3.151 
(0.291) 
Intellectual disability level
 a
 1 = borderline; 2 = mild; 3 = moderate; 4 = severe; 
5 = profound 
n1 = 20; n2= 57; n3 = 86; 
n4= 114; n5 = 109  
ES 1 -2.507 (1.288); ES 2 -2.482 
(0.748); ES 3 -3.723 (0.585); ES4 -
2.551 (0.512); ES 5 -2.763 (0.538) 
Sensory impairment 0 = no sensory impairment; 1 = sensory impairment n0 = 561; n1= 37 ES 0 -2.929 (0.232); ES 1 -3.417 
(0.803) 
Motor impairment 0 = no motor impairment; 1 = motor impairment n0 = 539; n1= 59 ES 0 -2.986(0.237); ES 1 -2.798 
(0.645) 
Communicative impairment 0 = no communicative impairment; 1 = 
communicative impairment 
n0 = 158; n1= 440 ES 0 -2.965 (0.437); ES 1 -2.955 
(0.255) 
Design 
 
 
Pretreatment functional analysis 
 
Primary treatment setting 
1 = AB-design; 2 = reversal design; 3 = multiple 
baseline design; 4 = alternating treatments design 
 
0 = no pretreatment functional analysis; 1 = 
pretreatment functional analysis 
1 = community environment; 2 = home; 3 = school; 
4 = treatment facility 
n1 = 126; n2= 257; n3 = 
145; n4= 70 
 
n0 = 173; n1= 425 
 
n1 = 15; n2= 71; n3 = 131; 
n4= 374 
ES 1 -2.187 (0.499); ES 2 -2.710 
(0.322); ES 3 -4.218 (0.456); ES4 -
2.682 (0.612) 
ES 0 -2.293 (0.439); ES 1 -3.156 
(0.260) 
ES 1 -3.067 (1.413); ES 2 -2.711 
(0.298); ES 3 -3.184 (0.341); ES4 -
2.915 (0.254) 
Primary intervention agent 1 = investigator; 2 = parent; 3 = peer; 4 = staff; 5 = 
teacher; 6 = therapist 
n1 = 58; n2= 64; n3 = 3; n4= 
93; n5 = 47; n6 = 327 
ES 1 -2.885 (0.722); ES 2 -2.055 
(0.695); ES 3 -4.358 (3.241); ES4 -
4.074 (0.646); ES 5 -2.921 (0.775); 
ES 6 -2.881 (0.295) 
Duration of treatment 
 
 
 
Intervention format 
1 = 1–5 weeks; 2 = 6–10 weeks; 3 = 11–15 weeks; 
4 = 16–20 weeks; 5 = more than 20 weeks; 6 = not 
reported 
 
0 = one-to-one; 1 = group intervention 
n1 = 32; n2= 26; n3 = 11; 
n4= 4; n5 = 134; n6 = 391 
 
 
n0 = 568; n1= 30 
ES 1 -2.221 (0.951); ES 2 -2.980 
(1.070); ES 3 -2.741 (1.615); ES4 -
0.758 (2.665); ES 5 -2.605 (0.493); 
ES 6 -3.158 (0.276) 
ES 0 -3.012 (0.229); ES 1 -1.359 
(1.093) 
Family involved in treatment 0 = no family involved; 1 = family involved n0 = 496; n1= 102 ES 0 -3.093 (0.246); ES 1 -2.332 
(0.539) 
Peer(s) involved in treatment 0 = no peer(s) involved; 1 = peer(s) involved n0 = 559; n1= 39 ES 0 -2.985 (0.232); ES 1 -2.340 
(0.941) 
Presence of data/researcher 
triangulation 
0 = no triangulation; 1 = triangulation n0 = 41; n1= 557 ES 0 -2.552 (0.839); ES 1 -2.997 
(0.234) 
Presence of follow-up data 0 = no follow-up; 1 = follow-up n0 = 399; n1= 199 ES 0 -2.980 (0.269); ES 1 -2.920 
(0.397) 
Uni- vs. multicomponent intervention 
 
Biological intervention 
0 = unicomponent intervention; 1 = 
multicomponent intervention 
0 = no bio-intervention component included; 1 = 
bio-intervention component included 
n0 = 137; n1= 461 
 
n0 = 520; n1= 78 
ES 0 -2.193 (0.483); ES 1 -3.165 
(0.251) 
ES 0 -3.112 (0.237); ES 1 -1.724 
(0.662) 
    Medication 0 = no medication; 1 = medication n0 = 534; n1= 64 ES 0 -3.056 (0.235); ES 1 -1.920 
(0.761) 
Psychological intervention 0 = no psycho-intervention component included; 1 
= psycho-intervention component included 
n0 = 94; n1= 504 ES 0 -2.388 (0.298); ES 1 -3.030 
(0.225) 
    Teaching alternative replacement 
skills 
0 = not teaching alternative replacement skills; 1 = 
teaching alternative replacement skills 
n0 = 405; n1= 193 ES 0 -2.742 (0.249); ES 1 -3.444 
(0.326) 
    Reward, praise, attention 0 = no reward, praise, attention; 1 = reward, praise, 
attention 
n0 = 290; n1= 308 ES 0 -2.481 (0.285); ES 1 -3.384 
(0.274) 
    Punishment 0 = no punishment; 1 = punishment n0 = 480; n1= 118 ES 0 -2.878 (0.253); ES 1 -3.214 
(0.485) 
    Use of restraints 0 = no use of restraints; 1 = use of restraints n0 = 562; n1= 36 ES 0 -2.964 (0.233); ES 1 -2.913 
(0.860) 
    Manipulating antecedent factors 0 = not manipulating antecedent factors; 1 = 
manipulating antecedent factors 
n0 = 366; n1= 232 ES 0 -2.765 (0.237); ES 1 -3.243 
(0.256) 
    Extinction 0 = no extinction; 1 = extinction n0 = 457; n1= 141 ES 0 -3.033 (0.256); ES 1 -2.720 
(0.465) 
    Gain insight in perception of CB 0 = not gaining insight in perception of CB; 1 = 
gain insight in perception of CB 
n0 = 534; n1= 64 ES 0 -2.990 (0.237); ES 1 -2.592 
(0.720) 
Social-contextual intervention 0 = no socio-intervention component included; 1 = 
socio-intervention component included 
n0 = 297; n1= 301 ES 0 -2.623 (0.318); ES 1 -3.293 
(0.313) 
    Informing, educating, training the 
environment                               
0 = not informing, educating, training the 
environment; 1 = informing, educating, training the 
environment 
n0 = 431; n1= 167 ES 0 -2.755 (0.261); ES 1 -3.530 
(0.429) 
    Adapt the environment to the 
participant’s needs 
0 = not adapting the environment to the 
participant’s needs; 1 = adapt the environment to 
the participant’s needs 
n0 = 361; n1= 237 ES 0 -2.563 (0.285); ES 1 -3.575 
(0.352) 
Publication year 
 
Study quality 
Continuous 
 
Continuous 
M = 2005; SD = 3.48; 
range = 2000-2011 
M = 6.803; SD = 1.609; 
range = 2-10 
0.002 (0.064) 
 
-0.417 (0.0315) 
Notes: M = mean; SD = standard deviation; CB = challenging behavior; ES = effect size; SE = standard error. 
a The variable ‘Intellectual disability level’ is included in Tables 3 and 4, but is not displayed in Table 5, since there were 32.7% missing 
values for this variable. We coded whether the participant had a borderline, mild, moderate, severe, or profound level of ID. For 32.7% of the 
included participants, the articles only mentioned that the participant had ID, but they did not describe the specific level of ID, nor could the 
level of ID be deduced from described test results. Since the applied analysis methods only work with participants without missing values, 
we decided to not include this variable in the remaining analysis. 
  
 
 
  
Table 5 
Parameter estimates and standard errors for the multilevel meta-analysis of the single-case and small-n studies. 
 Model 1 Model 2 Model 3 
Fixed effects    
    Mean treatment effect -2.96 (0.23) ***  -2.00 (0.47) *** 
    Moderator effect of    
       Age  -0.06 (0.02) ** -0.04 (0.02) * 
       Gender  -0.27 (0.48)  
       CB type – Self-injurious behavior  -0.13 (0.16)  
       CB type – Stereotyped behavior  -0.30 (0.24)  
       CB type – Aggression  1.18 (0.11) *** 1.01 (0.10) *** 
       CB type – Destructive behavior  0.32 (0.12) ** 0.21 (0.12) 
       CB type – Disruptive behavior  0.25 (0.13)  
       Diagnosis of autism spectrum disorder  -1.24 (0.36) *** -0.95 (0.33) ** 
       Sensory impairment  0.26 (0.90)  
       Motor impairment  -0.04 (0.74)  
       Communicative impairment  1.14 (0.60)  
       Design  -0.36 (0.30)  
       Pretreatment functional analysis  -0.16 (0.72)  
       Primary treatment setting  -0.11 (0.12)  
       Primary intervention agent  -0.09 (0.19)  
       Duration of treatment   -0.08 (0.20)  
       Intervention format  3.26 (2.49)  
       Family involved in treatment  0.25 (0.91)  
       Peer(s) involved in treatment  1.05 (1.93)  
       Presence of data/researcher triangulation  -1.01 (1.14)  
       Presence of follow-up data  -0.19 (0.58)  
       Uni- vs. multicomponent intervention  0.11 (0.77)  
       Biological intervention  3.43 (1.76)  
           Medication  -2.24 (2.04)  
       Psychological intervention  0.66 (0.59)  
           Teaching alternative replacement skills  -0.44 (0.51)  
           Reward, praise, attention  -0.66 (0.53)  
           Punishment  -0.19 (0.64)  
           Use of restraints  -0.01 (0.96)  
           Manipulating antecedent factors  -1.52 (0.54) ** -0.50 (0.21) * 
           Extinction  0.03 (0.62)  
           Gain insight in perception of CB  0.02 (1.26)  
       Social-contextual intervention  1.86 (1.28)  
           Informing, educating, training the environment                                -2.30 (0.86) ** -0.92 (0.53) 
           Adapt the environment to the participant’s needs  -1.77 (1.06)  
       Publication year  -0.04 (0.07)  
       Study quality  0.09 (0.21)  
Variance of effect    
    Between studies
 a
 3.32 (0.91) *** 2.51 (1.18) * 3.33 (0.97) ** 
    Between participants
 b
 20.57 (1.37) *** 21.90 (1.62) *** 20.40 (1.42) *** 
Residual variance 1.00 (0.01) *** 0.99 (0.01) *** 0.99 (0.01) *** 
Note: * = statistically significant effect: p < .05; ** = p < .01; *** = p < .001 
a 
Variance of effect between studies for Model 1 for the database without the most extreme outlying participant: 4.30 (1.02) ***; for the 
database without the six most extreme outlying participants: 3.72 (0.54) *** 
 
b 
Variance of effect between participants for Model 1 for the database without the most extreme outlying participant: 11.76 (0.95) ***; for 
the database without the six most extreme outlying participants: 3.48 (0.30) *** 
 
  
 Figure 1: Box and whisker diagram of the standardized random effects for the individual 
participants. 
 
  
 Figure 2: Funnel plot for publication bias: Each black dot represents the observed outcome 
for one participant.  
